Calcium is a universal second messenger. The temporal and spatial information that is encoded in Ca# + -transients drives processes as diverse as neurotransmitter secretion, axonal outgrowth, immune responses and muscle contraction. Ca# + -release from intracellular Ca# + stores can be triggered by diffusible second messengers like InsP $ , cyclic ADP-ribose or nicotinic acid-adenine dinucleotide phosphate (NAADP). A target has not yet been identified for the latter messenger. In the present study we show that nanomolar concentrations of NAADP trigger Ca# + -release from skeletal muscle sarcoplasmic reticulum. This was due to a direct action on the Ca# + -release channel\ryanodine receptor type-1, since in single channel recordings, NAADP increased the open probability of the purified channel protein.
INTRODUCTION
Ca# + is an essential and universal intracellular messenger, and in most cells intracellular stores play a prominent role in initiating Ca# + responses [1] . These intracellular stores are controlled by second messengers, which trigger Ca# + -release by acting on ligand-gated ion channels. The currently known second messenger-controlled intracellular Ca# + -channels comprise two families, the inositol 1,4,5-triphosphate (InsP $ )-receptors and the ryanodine receptors. The members of the InsP $ -receptor family are controlled by receptors that activate phospholipase C-isoforms and thereby generate InsP $ [2] . In contrast, the type 2 (cardiac isoform) and type 3 (brain isoform) ryanodine receptors are thought to function mainly as channels for Ca# + -induced Ca# + -release, and thus require the influx of trigger Ca# + [3] . Opening of the skeletal muscle (type 1) ryanodine receptor is controlled by a direct interaction of the sarcolemmal L-type Ca# + -channel, which acts as the voltage-sensor [4] . In addition, the activity of the ryanodine receptor\Ca# + -release channel can be modulated by several endogenous (e.g. calmodulin, ATP) and exogenous ligands (ranging from the eponymic plant alkaloid ryanodine to suramin analogues) (reviewed in [5, 6] ).
In the past decade, two additional second messengers, cyclic ADP-ribose (cADP-ribose) and nicotinic acid-adenine dinucleotide phosphate (NAADP) were identified as controlling Ca# + -release from intracellular stores. These new second messengers were originally found in sea urchin eggs but it is, at present, well appreciated that they are ubiquitously found in multi-cellular organisms as diverse as mammalian and plant cells (reviewed in [7] [8] [9] [10] ). Both nucleotides can be synthesized by the same class of Abbreviations used : AMP-PNP, βγ-imidoadenosine 5h-triphosphate ; cADP-ribose, cyclic ADP-ribose ; cGDP-ribose, cyclic GDP-ribose ; HSR, heavy sarcoplasmic reticulum ; NAADP, nicotinic acid-adenine dinucleotide 2h-phosphate ; 2hNADP, nicotinamide-adenine dinucleotide 2h-phosphate ; 3hNADP, nicotinamide-adenine dinucleotide 3h-phosphate ; NGD, nicotinamide-guanine dinucleotide. 1 To whom correspondence should be addressed (e-mail : martin.hohenegger!univie.ac.at).
range (EC &! $ 30 nM) and were specific because (i) they were blocked by Ruthenium Red and ryanodine, (ii) the precursor of NAADP, NADP, was ineffective at equimolar concentrations, (iii) NAADP did not affect the conductance and reversal potential of the ryanodine receptor. Finally, we also detected an ADPribosyl cyclase activity in the sarcoplasmic reticulum fraction of skeletal muscle. This enzyme was not only capable of synthesizing cyclic GDP-ribose but also NAADP, with an activity of 0.25 nmol\mg\min. Thus, we conclude that NAADP is generated in the vicinity of type 1 ryanodine receptor and leads to activation of this ion channel.
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enzymes, the ADP-ribosyl cyclase isoforms [11] . The mammalian family of ADP-ribosyl cyclases includes several poorly characterized enzymes ; in contrast, the enzymology of CD38, a surface antigen of T-lymphocytes, is well characterized [11] and it is thus generally accepted that the enzyme is versatile enough to allow for the production of both cADP-ribose and NAADP by using NAD or NADP respectively [11] .
Several recent studies have addressed the possibility that cADP-ribose and\or NAADP may release Ca# + from intracellular stores by affecting ryanodine receptor isoforms either directly or indirectly [7] . This search was inspired by the observation that, in sea urchin eggs, an intracellular Ca# + -release channel, which is apparently related to the mammalian ryanodine receptors, was stimulated by cADP-ribose (reviewed in [7, 12] ). However, the evidence obtained with vertebrate ryanodine receptor isoforms has been inconclusive. In Jurkat T-lymphocytes the Ca# + -releasing actions of cADP-ribose is apparently accounted for by efflux from a ryanodine receptor-controlled pool [13] . However, in other mammalian tissues, in particular the myocardium, the concentrations of cADP-ribose required to trigger Ca# + -release by ryanodine receptor activation were very high, i.e. in the micromolar range [14] , and NAD, the precursor of cADPribose, or the breakdown product ADP ribose, were also effective [15] .
In sea urchin eggs, NAADP-dependent Ca# + -release displayed unique pharmacological properties, such that a direct action on the ryanodine receptor was considered improbable [12] . Nevertheless, when assayed directly, binding sites for NAADP in mammalian tissue were found to differ substantially from the binding sites identified in sea urchin eggs [16] . Recently, Chini and co-workers described the synthesis of NAADP in a variety of mammalian tissues, including skeletal muscle [17] . While they have found coincidence of NAADP production and NAADPinduced Ca# + -release in brain, heart, spleen and pancreas, the skeletal muscle was not investigated for a possible NAADPsensitive Ca# + pool.
We therefore examined the hypothesis that NAADP acted on the sarcoplasmic reticulum from skeletal muscle, which contains essentially a single form of the ryanodine receptors, namely the type 1 isoform. Our experiments show that NAADP, but not NADP or cADP-ribose, triggers Ca# + -release from the sarcoplasmic reticulum at nanomolar concentrations and that the purified ryanodine receptor is a direct target of NAADP.
MATERIALS AND METHODS

Materials
NAD, nicotinamide-adenine dinucleotide 2h-phosphate (2h-NADP), nicotinamide-adenine dinucleotide 3h-phosphate (3h-NADP), NAADP, nicotinamide-guanine dinucleotide (NGD), cADP-ribose, cyclic GDP-ribose (cGDP-ribose), βγ-imidoadenosine 5h-triphosphate (AMP-PNP), Ruthenium Red, suramin, Ponceau S and leupeptin were purchased from Sigma (St. Louis, MI, U.S.A.). Alternatively, NAD, 2h-NADP and protease inhibitors were obtained from Roche Diagnostics (Vienna, Austria). [$H]Ryanodine and the horseradish peroxidase-coupled anti-mouse antibody was from AmershamPharmacia (Freiburg, Germany) and lipids from Avanti Polar Lipids (Birmingham, LA, U.S.A.). The monoclonal antibody directed against the ryanodine receptor (clone 34C) was from Biomol (Hamburg, Germany) and the reagents for enhanced chemiluminescence detection were from Pierce (Rockford, IL, U.S.A.). All other reagents were of analytical grade.
Protein preparations
Heavy sarcoplasmic reticulum (HSR) membranes were prepared from rabbit white skeletal muscle as described previously [18, 19] . For ryanodine receptor purification, the HSR membranes were solubilized in 1 % CHAPS (w\v) and the soluble fraction was used as a starting material to purify the ryanodine receptor by sucrose density centrifugation [20] . The proteoliposomes containing the purified ryanodine receptor were stored at k80 mC. The purity of the preparation was assessed by SDS\PAGE. Proteins were either visualized by staining with silver or, alternatively, transferred to nitrocellulose membranes and detected by Ponceau S. [$H]Ryanodine binding was carried out as outlined previously [18] .
ADP-ribosyl cyclase activity
ADP-ribosyl cyclase activity was determined by an assay that relies on the fluorescence increase caused by the formation of cGDP-ribose from NGD. The reaction was carried out in 250 µl buffer I, containing 20 mM Hepes\NaOH (pH 7.2), 0.5 mM MgCl # , 0.45 mM CaCl # , 0.5 mM EGTA, 15 mM NaCl and 125 mM KCl. HSR (50-70 µg) was allowed to equilibrate for 2 min before the reaction was started with 100 µM NGD. The fluorescence intensity was monitored at an excitation wavelength of 300 nm and an emission wavelength of 410 nm (using an F-4500 Hitachi fluorescence photometer). A calibration curve was generated with appropriate dilutions of cGDP-ribose to calculate the molar amount of cGDP-ribose formed by enzymatic action.
For the base-exchange reaction, the purified ADP-ribosyl cyclase (4 µg\ml) from Aplysia (Sigma) or HSR membranes (1 mg\ml) were incubated with 500 µM NADP, 1 mM nicotinic acid and buffer I, adjusted to a final pH of 5.0. The reaction mixture was incubated for 1 h at 37 mC in the dark and was immediately loaded onto an HPLC system for separation of the nucleotides.
HPLC analysis
Nucleotides from the base-exchange reaction were separated on an AG MP-1 column (4.6 mmi26 mm, Bio-Rad) using a Hitachi HPLC system. The column was equilibrated in 100 % buffer A (water). The nucleotides were detected at 257 nm and eluted by a nonlinear gradient of trifluoroacetic acid at a flow rate of 1 ml\min : 0-2 min, 2 % B ; 2-5 min, 4 % B ; 5-9 min, 8 % B; 9-13 min, 16 % B ; 13-20 min, 32 % B ; 20-23 min, 100 % B (150 mM trifluoroacetic acid) ; 23-30 min, 0 % B. The specific activity of NAADP formation was determined from the area under curve of the NAADP peak and expressed as nmol\mg\min. 2), 120 mM KCl, 15 mM NaCl, 5 mM NaN $ and a cocktail of protease inhibitors (0.5 µg\ml leupeptin, 1.4 µg\ml aprotinin, 1 µM pepstatin and 0.1 mM PMSF). After 24 h at 4 mC the HSR was diluted 100-or 200-fold in a nominally calcium-free loading buffer supplemented with 2 mM EGTA, 5 mM MgCl # and loaded onto a Bio-Logic rapid filtration system [21] . The HSR (50-100 µg) was kept on the filter (ME 26 ; Schleicher & Schuell, Dassel, Germany) and rinsed for the indicated times with release buffer, containing 50 mM Mops\Tris (pH 7.2), 120 mM KCl, 15 mM NaCl, 5 mM NaN $ and the compounds indicated in the figure legends. In some experiments the pH of the buffer was set to 7.0 or 7.4. The free Ca# + concentration was adjusted by the ratio of CaCl # and EGTA, using the algorithm and the stability constants of Schoenmaker and co-workers [22] . Time points longer than 10 s were determined manually using a conventional filtration device. The initial load was determined by extrapolation of the Ca# + -release curve, with release buffer supplemented with 5 mM MgCl # and 20 µM Ruthenium Red at the start point of the release reaction. In order to determine the rapid Ca# + -release rate the reaction was monitored over 30 s and the data points were fitted to a twoexponential equation [21] .
Release of
Single channel recordings
The purified ryanodine receptor was fused into lipid bilayers formed by mixing phosphatidylserine and phosphatidylethanolamine in a 1 : 1 ratio (each dissolved in decane at 10 mg\ml). Single-channel recordings were carried out as described previously [19, 20] . The cis-chamber and the trans-chamber were connected to the head-stage input of an EPC-9 amplifier (Heka Elektronik, Lambrecht, FRG) ; the trans-bath was held on virtual ground and Cs + was used as a charge carrier. The buffer composition in the cis-chamber was 10 mM Hepes\Tris (pH 7.4), 0.02-0.1 mM CaCl # and 480 mM CsCl, and in the trans-chamber, 10 mM Hepes\Tris (pH 7.4) and 50 mM CsCl. Purified Ca# + -release channel\type 1 ryanodine receptor (1.5-2 µg) and other reagents were added to the cis-chamber. Recordings were filtered at 4 kHz through a low-pass Bessel filter, digitized at 40 kHz and subsequently stored on an Apple Macintosh computer. Single-channel events were analysed with TAC V2.5 software (Skalar Instruments, Seattle, WA). Mean open probability (P o ) of channels and Type 1 ryanodine receptor activation by nicotinic acid-adenine dinucleotide phosphate the corresponding lifetimes (τ) of the open and closed events were identified by a 50 % threshold analysis. The holding potentials given in the figure legends were applied with reference to the trans-chamber. All experiments were carried out at 22-24 mC.
Miscellaneous procedures
Curve fitting was carried out using the standard MaquartLevenberg algorithm provided by Sigma Plot (Jandl, San Rafael, CA). Statistical analysis was carried out by Students t-test and, for multiple comparisons, by ANOVA and Scheffe's post hoc test. Experiments were carried out at least three times and data are given as meanpS.D., if not otherwise stated.
RESULTS
ADP-ribosyl cyclase activity in the sarcoplasmic reticulum
In order to search for ADP-ribosyl cyclase activity in the HSR, we made use of the fact that these enzymes accept NGD as substrate to form the fluorescent product cGDP-ribose ( Figure  1A ). Neither NGD nor GDP-ribose emit fluorescence at the wavelength pair employed. Hence, the experimental approach is
Figure 1 Characterization of ADP-ribosyl cyclase activity in the skeletal muscle HSR
(A) The formation of fluorescent cyclic GDP-ribose was monitored after the addition of 100 µM NGD, indicated by the arrow. The enzyme activity was calculated from linear regression which is overlaid on the increasing fluorescence trace after the addition of NGD. (B) The substrate saturation curve was generated under identical conditions. The inset depicts the LineweaverBurke transformation of the data.
Table 1 Enrichment of cGDP-ribose activity in HSR membranes
Three independent preparations of HSR were monitored for cGDP-formation under experimental conditions similar to those desciribed in Figure 1 (A), using 100 µM NGD to initiate the reaction. The post-nuclear homogenate represents a precleared 4000 g supernatant which was termed the starting material. The first 30 000 g supernatant corresponds to the ' cytosolic ' fraction of the preparation. suitable to continuously measure ADP-ribosyl cyclase activity, and to discriminate these enzymes from unrelated NADases [23] . During rabbit skeletal muscle HSR preparation, ADP-ribosyl cyclase activity was enriched approximately 12-fold compared with the starting material (post-nuclear homogenate ; Table 1 ). During the first centrifugation step we lost 50 % of the enzyme activity. The remaining functional enzyme was recovered throughout the consecutive purification steps. Two pools with ADP-ribosyl cyclase activity were identified. The first pool was in the ' cytosolic ' fraction (supernatant of the first 30 000 g pellet), where we recovered 39 % of the enzyme activity, which most likely is due to a soluble ADP-ribosyl cyclase isoform. From the second pool, the 30 000 g pellet, myosin and associated cytoskeletal proteins were extracted with 600 mM KCl. However, the enzyme activity resisted the high ionic strength, and was retained in the 100 000 g pellet of the HSR. This observation suggests that the ADP-ribosyl cyclase of the HSR is an integral membrane protein, rather than a membrane-associated protein. The highaffinity [$H]ryanodine-binding was carried out in parallel and enriched approximately 100-fold in the HSR compared with the starting material. The relatively high ADP-ribosyl cyclase activity in the post-nuclear homogenate, and possible sub-optimal assay conditions for the enzyme, may explain the discrepancy in the enrichment factors. Nevertheless, the ADP-ribosyl cyclase activity in the HSR was characterized by saturation isotherms and found to peak at 92.2p10.3 nmol : mg −" : min −" ( Figure 1B ). NGD was utilized with a K m of 53.3p6.9 µM. This apparent affinity of the substrate is comparable to estimates of K m observed with the isoforms found in T-lymphocytes (13 µM) [24] and Aplysia (119 µM) [25] .
In addition to the cyclization reaction described by the formation of cGDP-ribose (Figure 1 ), the family of ADP-ribosyl cyclases have also been shown to catalyse a base-exchange reaction, to form NAADP from NADP and nicotinic acid [7, 9, 11, 17] . In the present study, the reactants and products of the base-exchange reaction were separated on an anion-exchange column ( Figure 2 ). The purified ADP-ribosyl cyclase from Aplysia was used as a standard and reached an activity of 1.2 µmol NAADP\mg\min ( Figure 2C ). Under identical ionic conditions, but using HSR as a source for ADP-ribosyl cyclase, an activity of 0.25p0.05 nmol NAADP\mg\min (meanpS.D., n l 3) was detectable ( Figure 2D ) and a symmetric NAADP peak eluted at 27.4 minutes (inset in Figure 2D ).
NAADP-promoted Ca 2 + -release from HSR vesicles
The principal function of the HSR in skeletal muscle is the storage and release of Ca# + [1, 6, 26] . Because of the presence of an ADP-ribosyl cyclase in the HSR, and its ability to synthesize NAADP, it was reasonable to postulate that the reaction product NAADP may affect Ca# + -release. We therefore measured the rate of Ca# + -efflux from passively loaded HSR vesicles by employing a rapid filtration device. Using this approach, incubation times in the sub-second range are possible and, thus, the complex kinetics of Ca# + -induced Ca# + -efflux can be resolved [21] . As can be seen from Figure 3(A) , there are at least two phases of Ca# + -release. Under basal conditions the initial rapid Ca# + -release proceeded with a rate of 0.55p0.26 s −" (n l 7). These data were obtained from pooling three individual HSR preparations which may explain the mean variation. In the presence of 300 nM NAADP (triangles in Figure 3A ), the initial efflux was significantly accelerated (rate l 1.88p0.3 s −" ; n l 4, P l 0.005). It is evident from the logarithmic transformation depicted in the inset of Figure 3 (A) that NAADP did not affect the second, slower component of Ca# + -efflux. NAADP triggered the initial rapid Ca# + -release ( Figure 3B ) with an EC &! of 32.8p9.8 nM. This effect was specific, because at a concentration of 300 nM the precursor of NAADP, 2h-NADP, or the alternative reaction product, cADP-ribose, had no significant effect on rapid Ca# + -release (control : 0.39p0.19 s −" ; 2h-NADP : 0.25p 0.12 s −" , cADP-ribose : 0.27p0.05 s −" ; meanpS.E.M., n l 3; experimental conditions as in Figure 3A) .
Ca# + -release through the ryanodine receptors is subject to a bell-shaped regulation by Ca# + , i.e. activation in the presence of submicromolar Ca# + and inhibition at millimolar concentrations of Ca# + . Several ryanodine receptor ligands, including caffeine [27] , suramin [18, 28] and the suramin analogue NF307 [18] , sensitize the skeletal muscle ryanodine receptor to stimulation by Ca# + . In order to prove this conjecture for NAADP, the free Ca# + concentration in the release medium was varied from virtually zero to 10 mM ( Figure 3C ). NAADP accelerated the rate of Ca# + -release over the entire Ca# + concentration range but a shift in the EC &! of activating Ca# + was not observed (control : 0.28p0.06 µM ; 300 nM NAADP 0.27p0.03 µM). Interestingly, in the presence of 300 nM NAADP, millimolar concentrations of Ca# + were less effective in preventing activation of the ryanodine receptor. This effect was also observed previously for suramin, a ryanodine receptor-channel opener [28] . In the present study, the pH of the release medium was also varied from 7.0 to 7.4. However, there was no significant difference in Ca# + -release rates Type 1 ryanodine receptor activation by nicotinic acid-adenine dinucleotide phosphate with 100 or 300 nM NAADP at pH 7.0, 7.2 or 7.4 (results not shown).
We have verified that NAADP-triggered Ca# + -release occurred through the ryanodine receptor\Ca# + release-channel by the following pharmacological criteria : (i) Ruthenium Red is a blocker of the ryanodine receptor at concentrations in the low micromolar range [29] . Accordingly, the NAADP-induced, rapid Ca# + -release was abrogated by 2 µM Ruthenium Red ( Figure  4A ). (ii) The dual actions of the plant alkaloid ryanodine, activation at low nanomolar concentrations and inhibition at micromolar concentrations, were used to induce Ca# + -release and to block NAADP-induced Ca# + -release ( Figures 4B and 4C) . However, the association of ryanodine to the inhibitory binding site proceeds very slowly. Hence, it is difficult to achieve a complete inhibition within the time scale used in rapid filtration experiments. In order to overcome this experimental limitation we exploited the very slow dissociation of ryanodine from the low affinity binding site [28] . Preincubation with 20 or 120 µM ryanodine prior to the Ca# + -release experiments prevented Ca# + -and NAADP-induced Ca# + -release in a dose-dependent fashion ( Figure 4B ). (iii) If the Ca# + -releasing effect of NAADP is mediated through its action on the ryanodine receptor, the combination of NAADP and other ryanodine receptor-channel openers should be non-additive when assayed at a time point where the NAADP-stimulated rapid release approaches completion, i.e. after 5 s (cf. Figure 3A) . It is evident from Figure 4 (C) that 5 s after stimulation, the amounts of vesicle-trapped [%&Ca# + ] were comparable, regardless of whether each individual compound (caffeine or AMP-PNP) was added alone or in combination with NAADP. Finally, the effect of NAADP was similar in magnitude to the effect of 10 nM ryanodine, i.e. a concentration that activates the ryanodine receptor. Based on these observations, we conclude that NAADP releases Ca# + from the same vesicle population, and hence from the same store, as ryanodine receptor channel-openers. The fact that NAADP and AMP-PNP were not additive in releasing Ca# + from HSR does not prove that NAADP is ineffective in the presence of AMP-PNP. It is possible that NAADP accelerates only the initial Ca# + -release rate, which should be detectable in the initial time points. As shown in Figure 4(D) , within 250 ms the amount of intravesicular Ca# + is significantly diminished in the presence of 300 nM NAADP or 0.4 mM AMP-PNP (multiple comparison using ANOVA and post hoc Scheffe test ; P 0.0001). Furthermore, using a saturating concentration of 300 nM NAADP, the Ca# + -release was significantly augmented by the coadministration of 0.4 mM AMP-PNP compared with AMP-PNP alone (P 0.05). Taken together, these data provide evidence that even in the presence of an adenine nucleotide, NAADP preserves its Ca# + -mobilizing ability.
Direct activation of the type 1 ryanodine receptor channel by NAADP
In order to confirm that the NAADP-induced Ca# + -release arises from a direct interaction with the ryanodine receptor, singlechannel recordings were carried out with the purified ryanodine receptor. A protein stain and the corresponding immunoblot Single-channel currents of the purified ryanodine receptor were recorded at a holding potential of 20 mV under conditions given in the legend to Figure 3 . Open probabilities and amplitudes are shown as meanspS.E.M. and the number of experiments is given in parentheses. *Single-factor analysis of variance (ANOVA) and subsequent Scheffe! post hoc comparison of the data identified significant difference between controls and NAADP-induced open probabilities as indicated (P 0.0005).
Open probability
Amplitude (pA) analysis of a representative purified ryanodine receptor preparation is shown in Figure 5 . After inserting the channel protein in artificial lipid bilayers, NAADP increased the open probability in a concentration-dependent manner ( Figure 6 , Table 2 ). An EC &! of 31.2p6.9 nM was estimated from the concentrationresponse curve ( Figure 6B ), which is similar to the estimate obtained in Ca# + -release experiments. NAADP was only effective when added from the cytosolic (cis) side of the channel. The single-channel current amplitude was not altered by the addition of increasing concentrations of NAADP (Table 2) . NAADPmediated activation of the ryanodine receptor (exemplified for 100 nM NAADP) increased the mean open duration (T o ) and shortened the mean closed duration (T c ) significantly (Table 3) . In line with these findings, the open time constant (τ o" ) was significantly increased, whilst the close time constant (τ c" ) was significantly reduced compared with control (Table 3) . Thus, the increase in the open probability by the application of NAADP was, at least in part, due to longer open states of the channel protein. For comparison, an electrophysiological analysis was carried out in parallel with the universal ryanodine receptor agonist suramin [28, 30] . At saturating suramin concentrations (900 µM), we determined an open probability of 0.82p0.03, a value similar to previous reports [20, 28] . Although the open probabilities after addition of suramin or of NAADP are reasonably similar in magnitude, the compounds achieve this increase in open probability by distinct actions : in the presence of suramin, the channel is shifted into a state with long open times (τ o# and τ o$ in Table 3 ). In contrast, NAADP does not alter the distribution of open states but, as stated above, prolongs τ o" (Table 3 ). In 4 out of 19 single channel recording experiments, an increase in the open probability on sequential addition of 50-200 nM NAADP was followed by a decline of the open probability on further addition of NAADP. The reason for this reduction in the open probability is unknown. In two out of these four experiments, the Ca# + -release channel could be reactivated by 15-30 µM NAADP. From these experiments it is concluded that, in contrast to the observations in the sea urchin eggs and pancreatic acinar cells, the purified skeletal muscle ryanodine receptor is not desensitized upon addition of nanomolar or micromolar concentrations of NAADP [7, 12] .
The ryanodine receptor displays a linear current-voltage relationship at holding potentials ranging from k20 mV to 60 mV (data not shown). Unitary currents were measured under conditions similar to those given in Figure 6 , in the absence and presence of 2 µM NAADP. The calculated reversal potentials were virtually identical (k48.9 mV in the absence and k49.8 mV in the presence of 2 µM NAADP). Similarly, the conductance (estimated from the slope of the regression line) was not affected Type 1 ryanodine receptor activation by nicotinic acid-adenine dinucleotide phosphate Control for NAADP (n l 13) 100 nM NAADP (n l 13) Control for suramin (n l 8) 0.9 mM suramin (n l 8) by NAADP (control : 538 pS ; 2 µM NAADP : 526 pS). The high conductance of approximately 530 pS is typical for recordings performed with Cs + as the charge carrier [6] and essentially identical to our previous observations [20] . We confirmed that NAADP specifically activated the ryanodine receptor by the following experiments. The ryanodinereceptor blocker, Ruthenium Red, completely abrogated the currents elicited by a high (saturating) concentration of NAADP and the channel was locked in the closed state ( Figure 7) . Finally, we also tested the enzymatic precursor of NAADP, 2h-NADP, which did not activate the purified ryanodine receptor in singlechannel recordings. At 300 nM, a concentration at which NAADP fully activated the channel (see Figure 6B and Table 2 ), 2h-NADP did not have any appreciable effect (control : P o l 0.402p0.049, n l 8 ; 300 nM 2h-NADP : P o l 0.458p0.076, n l 8). 3h-NADP was also investigated in order to evaluate the importance of the position of the ribosyl phosphate group ; this analogue was also not effective in stimulating the Ca# + -release channel (control : P o l 0.44p0.06 ; n l 4 ; 300 nM 3h-NADP : P o l 0.45p0.07, n l 4).
DISCUSSION
In the present work, we provide compelling evidence for a direct action of NAADP on the skeletal muscle ryanodine receptor type 1. We show that NAADP triggered rapid Ca# + -release from skeletal muscle sarcoplasmic reticulum and that this release was dependent on the type 1 ryanodine receptor because it was blocked by Ruthenium Red and micromolar concentrations of ryanodine. The Ca# + pool controlled by NAADP was similar in size to that controlled by typical ryanodine receptor channel openers (caffeine, AMP-PNP and, at nanomolar concentrations, ryanodine). The ability of NAADP to release Ca# + from HSR vesicles can be fully accounted for by an NAADP-dependent direct activation of the ryanodine receptor. Both Ca# + -release from HSR and single channel currents of the purified ryanodine receptor were activated by NAADP, with essentially identical EC &! values of $ 30 nM. Finally, NAADP-activated singlechannel currents did not differ in conductance and reversal potential from the Ca# + -activated currents, and Ruthenium Red completely abrogated NAADP-activated single channel currents. These two sets of observations rule out the possibility that the electrophysiological effects of NAADP were due to its action on a different channel protein that contaminated the purified ryanodine receptor preparation. Although unlikely, it cannot be ruled out that an accessory protein tightly associated with the ryanodine receptor is mediating the NAADP-induced activation.
The action of NAADP on both Ca# + -release and single-channel currents was specific because it was mimicked neither by the precursor substrate 2h-NADP nor by the alternative product of the enzymatic reaction, cADP-ribose. Similarly, 3h-NADP, a structural analogue of 2h-NADP, was ineffective. This indicates that it is not the relative position of the PO % -moiety but the nicotinic acid-moiety that is important for biological activity.
NAADP displays a high apparent affinity for the type 1 ryanodine receptor ; the EC &! ($ 30 nM) is comparable to that described for Ca# + -release in some mammalian cells, e.g. pancreatic acinar cells [31] and Jurkat T-lymphocytes [32] , as well as sea urchin eggs [33, 34] and plants [35] . Recently, the type 2 ryanodine receptor from dogs, which represents the cardiac isoform, was found to respond to NAADP in single-channel recordings at concentrations exceeding 1 µM [36] . However, it is not clear whether the effect of NAADP reflects a direct action on the ryanodine receptor, because experiments were evaluated on microsomal membrane preparations rather than on the purified ryanodine receptor. Bak and co-workers [37] observed that NAADP-triggered Ca# + -release from rabbit cardiac microsomes was blocked neither by inhibitors of the InsP $ -receptor nor by the specific ryanodine receptor blockers, ryanodine (100 µM) and Ruthenium Red (5 µM). Our experiments, however, show that, at comparable concentrations and under comparable experimental conditions, these compounds fully blocked Ca# + -release from skeletal muscle HSR vesicles. In part, our observations are controversial in the light of results recently published by Copello and co-workers [38] . NAADP and cADP-ribose had no effect on the Ca# + -uptake, nor could it effect open probability in single-channel recordings of sarcoplasmic reticulum membranes from rabbit skeletal muscle. We have not investigated Ca# + -uptake into the HSR in the presence of the Ca# + -releasing agents NAADP or cADP-ribose because conclusions on a possible Ca# + -release mechanism may only be drawn indirectly and therefore are not conclusive. However, we could confirm the finding that cADP-ribose is not able to induce Ca# + -release from HSR, but in contrast NAADP unequivocally triggers Ca# + -release (Figures 3 and 4) . The difference in the electrophysiological results of the present study and the investigation mentioned above are not clear. However, our experimental conditions differ markedly from those reported by Copello and co-workers [38] in the following ways : (i) we studied purified type 1 ryanodine receptor in electrophysiological experiments in contrast with sarcoplasmic reticulum fractions ; (ii) Cs + was used as a permeant ion instead of Ca# + ; (iii) in all electrophysiological experiments we have only analysed NAADP effects on single-channel recordings of the purified ryanodine receptor whereas Copello and co-workers have allowed multiple channel fusions, which may have occluded detection of a direct activation of a single ryanodine receptor by NAADP ; and (iv) under these conditions the ryanodine receptors exhibit a fast heterogeneity in gating, ranging from a very low open probability of less than 0.1 to greater than 0.8 (under identical conditions of 100 µM free Ca# + ). Moreover, calmodulin, which is known to inhibit the skeletal muscle ryanodine receptor in the presence of micromolar concentrations of Ca# + [6] , had only a modest or, in some cases, no effect on the open probability [38] .
Previously, ADP-ribosyl cyclase activity was observed in membrane fractions from cardiac ventricle [17, 39] and, more recently, from skeletal muscle homogenates [17, 40] . We confirmed that ADP-ribosyl cyclase activity is present in skeletal muscle. Throughout the preparation of the HSR, the membranes were exposed to 600 mM KCl, a high ionic strength that could not release ADP-ribosyl cyclase activity from the HSR. This is indicative for a tightly associated membrane protein or possibly an integral membrane protein. More importantly, we observed that ADP-ribosyl cyclase activity was substantially enriched in HSR vesicles, such that the specific activity was substantially higher than that determined in an unfractionated membrane preparations from skeletal muscle. In a recent report, the enzymatic formation of NAADP was directly measured in 100 000 g membranes from rat skeletal muscle and accounted to be 0.07 nmol\mg\min [17] . However, the ability of NAADP to release Ca# + in this tissue was not further investigated. We could confirm synthesis of NAADP in skeletal muscle membranes. With an activity of 0.25 nmol\mg\min, the ADP-ribosyl cyclase seems to be enriched in HSR membranes compared with the membranes used by Chini and co-workers [17] . Thus it is safe to conclude that in skeletal muscle the second messenger NAADP can be generated in the vicinity of its target, the type 1 ryanodine receptor. The physiological role of the NAADP induced Ca# + -release and ryanodine receptor activation is not clear at the moment.
